Medac Pharma: Medac hires HCB to promote RA drug
The drugmaker's lead product, Rasuvo, is an injectable version of a commonly prescribed drug used to treat rheumatoid arthritis.
Read full article »
CEO
Medac Pharma develops and commercializes mid-to-late stage molecule therapies for the treatment of autoimmune diseases and cancer.
Read more